Cargando…

Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid progression of disease and lack of biomarkers. Magnetic resonance imaging (MRI) has demonstrated its potential for detecting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallebage-Gamarallage, Menuka, Foxley, Sean, Menke, Ricarda A. L., Huszar, Istvan N., Jenkinson, Mark, Tendler, Benjamin C., Wang, Chaoyue, Jbabdi, Saad, Turner, Martin R., Miller, Karla L., Ansorge, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848544/
https://www.ncbi.nlm.nih.gov/pubmed/29529995
http://dx.doi.org/10.1186/s12868-018-0416-1
_version_ 1783305890331361280
author Pallebage-Gamarallage, Menuka
Foxley, Sean
Menke, Ricarda A. L.
Huszar, Istvan N.
Jenkinson, Mark
Tendler, Benjamin C.
Wang, Chaoyue
Jbabdi, Saad
Turner, Martin R.
Miller, Karla L.
Ansorge, Olaf
author_facet Pallebage-Gamarallage, Menuka
Foxley, Sean
Menke, Ricarda A. L.
Huszar, Istvan N.
Jenkinson, Mark
Tendler, Benjamin C.
Wang, Chaoyue
Jbabdi, Saad
Turner, Martin R.
Miller, Karla L.
Ansorge, Olaf
author_sort Pallebage-Gamarallage, Menuka
collection PubMed
description BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid progression of disease and lack of biomarkers. Magnetic resonance imaging (MRI) has demonstrated its potential for detecting the pathological signature and tracking disease progression in ALS. However, the microstructural and molecular pathological substrate is poorly understood and generally defined histologically. One route to understanding and validating the pathophysiological correlates of MRI signal changes in ALS is to directly compare MRI to histology in post mortem human brains. RESULTS: The article delineates a universal whole brain sampling strategy of pathologically relevant grey matter (cortical and subcortical) and white matter tracts of interest suitable for histological evaluation and direct correlation with MRI. A standardised systematic sampling strategy that was compatible with co-registration of images across modalities was established for regions representing phosphorylated 43-kDa TAR DNA-binding protein (pTDP-43) patterns that were topographically recognisable with defined neuroanatomical landmarks. Moreover, tractography-guided sampling facilitated accurate delineation of white matter tracts of interest. A digital photography pipeline at various stages of sampling and histological processing was established to account for structural deformations that might impact alignment and registration of histological images to MRI volumes. Combined with quantitative digital histology image analysis, the proposed sampling strategy is suitable for routine implementation in a high-throughput manner for acquisition of large-scale histology datasets. Proof of concept was determined in the spinal cord of an ALS patient where multiple MRI modalities (T1, T2, FA and MD) demonstrated sensitivity to axonal degeneration and associated heightened inflammatory changes in the lateral corticospinal tract. Furthermore, qualitative comparison of R2* and susceptibility maps in the motor cortex of 2 ALS patients demonstrated varying degrees of hyperintense signal changes compared to a control. Upon histological evaluation of the same region, intensity of signal changes in both modalities appeared to correspond primarily to the degree of microglial activation. CONCLUSION: The proposed post mortem whole brain sampling methodology enables the accurate intraindividual study of pathological propagation and comparison with quantitative MRI data, to more fully understand the relationship of imaging signal changes with underlying pathophysiology in ALS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12868-018-0416-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5848544
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58485442018-03-21 Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology Pallebage-Gamarallage, Menuka Foxley, Sean Menke, Ricarda A. L. Huszar, Istvan N. Jenkinson, Mark Tendler, Benjamin C. Wang, Chaoyue Jbabdi, Saad Turner, Martin R. Miller, Karla L. Ansorge, Olaf BMC Neurosci Methodology Article BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid progression of disease and lack of biomarkers. Magnetic resonance imaging (MRI) has demonstrated its potential for detecting the pathological signature and tracking disease progression in ALS. However, the microstructural and molecular pathological substrate is poorly understood and generally defined histologically. One route to understanding and validating the pathophysiological correlates of MRI signal changes in ALS is to directly compare MRI to histology in post mortem human brains. RESULTS: The article delineates a universal whole brain sampling strategy of pathologically relevant grey matter (cortical and subcortical) and white matter tracts of interest suitable for histological evaluation and direct correlation with MRI. A standardised systematic sampling strategy that was compatible with co-registration of images across modalities was established for regions representing phosphorylated 43-kDa TAR DNA-binding protein (pTDP-43) patterns that were topographically recognisable with defined neuroanatomical landmarks. Moreover, tractography-guided sampling facilitated accurate delineation of white matter tracts of interest. A digital photography pipeline at various stages of sampling and histological processing was established to account for structural deformations that might impact alignment and registration of histological images to MRI volumes. Combined with quantitative digital histology image analysis, the proposed sampling strategy is suitable for routine implementation in a high-throughput manner for acquisition of large-scale histology datasets. Proof of concept was determined in the spinal cord of an ALS patient where multiple MRI modalities (T1, T2, FA and MD) demonstrated sensitivity to axonal degeneration and associated heightened inflammatory changes in the lateral corticospinal tract. Furthermore, qualitative comparison of R2* and susceptibility maps in the motor cortex of 2 ALS patients demonstrated varying degrees of hyperintense signal changes compared to a control. Upon histological evaluation of the same region, intensity of signal changes in both modalities appeared to correspond primarily to the degree of microglial activation. CONCLUSION: The proposed post mortem whole brain sampling methodology enables the accurate intraindividual study of pathological propagation and comparison with quantitative MRI data, to more fully understand the relationship of imaging signal changes with underlying pathophysiology in ALS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12868-018-0416-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-13 /pmc/articles/PMC5848544/ /pubmed/29529995 http://dx.doi.org/10.1186/s12868-018-0416-1 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Pallebage-Gamarallage, Menuka
Foxley, Sean
Menke, Ricarda A. L.
Huszar, Istvan N.
Jenkinson, Mark
Tendler, Benjamin C.
Wang, Chaoyue
Jbabdi, Saad
Turner, Martin R.
Miller, Karla L.
Ansorge, Olaf
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology
title Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology
title_full Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology
title_fullStr Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology
title_full_unstemmed Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology
title_short Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology
title_sort dissecting the pathobiology of altered mri signal in amyotrophic lateral sclerosis: a post mortem whole brain sampling strategy for the integration of ultra-high-field mri and quantitative neuropathology
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848544/
https://www.ncbi.nlm.nih.gov/pubmed/29529995
http://dx.doi.org/10.1186/s12868-018-0416-1
work_keys_str_mv AT pallebagegamarallagemenuka dissectingthepathobiologyofalteredmrisignalinamyotrophiclateralsclerosisapostmortemwholebrainsamplingstrategyfortheintegrationofultrahighfieldmriandquantitativeneuropathology
AT foxleysean dissectingthepathobiologyofalteredmrisignalinamyotrophiclateralsclerosisapostmortemwholebrainsamplingstrategyfortheintegrationofultrahighfieldmriandquantitativeneuropathology
AT menkericardaal dissectingthepathobiologyofalteredmrisignalinamyotrophiclateralsclerosisapostmortemwholebrainsamplingstrategyfortheintegrationofultrahighfieldmriandquantitativeneuropathology
AT huszaristvann dissectingthepathobiologyofalteredmrisignalinamyotrophiclateralsclerosisapostmortemwholebrainsamplingstrategyfortheintegrationofultrahighfieldmriandquantitativeneuropathology
AT jenkinsonmark dissectingthepathobiologyofalteredmrisignalinamyotrophiclateralsclerosisapostmortemwholebrainsamplingstrategyfortheintegrationofultrahighfieldmriandquantitativeneuropathology
AT tendlerbenjaminc dissectingthepathobiologyofalteredmrisignalinamyotrophiclateralsclerosisapostmortemwholebrainsamplingstrategyfortheintegrationofultrahighfieldmriandquantitativeneuropathology
AT wangchaoyue dissectingthepathobiologyofalteredmrisignalinamyotrophiclateralsclerosisapostmortemwholebrainsamplingstrategyfortheintegrationofultrahighfieldmriandquantitativeneuropathology
AT jbabdisaad dissectingthepathobiologyofalteredmrisignalinamyotrophiclateralsclerosisapostmortemwholebrainsamplingstrategyfortheintegrationofultrahighfieldmriandquantitativeneuropathology
AT turnermartinr dissectingthepathobiologyofalteredmrisignalinamyotrophiclateralsclerosisapostmortemwholebrainsamplingstrategyfortheintegrationofultrahighfieldmriandquantitativeneuropathology
AT millerkarlal dissectingthepathobiologyofalteredmrisignalinamyotrophiclateralsclerosisapostmortemwholebrainsamplingstrategyfortheintegrationofultrahighfieldmriandquantitativeneuropathology
AT ansorgeolaf dissectingthepathobiologyofalteredmrisignalinamyotrophiclateralsclerosisapostmortemwholebrainsamplingstrategyfortheintegrationofultrahighfieldmriandquantitativeneuropathology